Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HDAC Inhibitor”

195 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 195 results

Testing effectiveness (Phase 2)Study completedNCT02948075
What this trial is testing

Safety and Efficacy of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy

Who this might be right for
Ovarian Cancer
NewVac LLC 31
Testing effectiveness (Phase 2)Study completedNCT00077194
What this trial is testing

FR901228 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Study completedNCT03382834
What this trial is testing

Selective Estrogen Receptor Modulators to Enhance the Efficacy of Viral Reactivation With Histone Deacetylase Inhibitors

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 31
Early research (Phase 1)Study completedNCT01583283
What this trial is testing

Study of ACY-1215 in Combination With Lenalidomide, and Dexamethasone in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 38
Testing effectiveness (Phase 2)Ended earlyNCT02805660
What this trial is testing

Phase 1/2 Study of Mocetinostat and Durvalumab in Patients With Advanced Solid Tumors and NSCLC

Who this might be right for
Advanced Cancer
Mirati Therapeutics Inc. 83
Testing effectiveness (Phase 2)Study completedNCT00134043
What this trial is testing

Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid Cancer

Who this might be right for
Insular Thyroid CancerRecurrent Thyroid CancerStage II Follicular Thyroid Cancer+4 more
National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)Looking for participantsNCT04512534
What this trial is testing

Sintilimab Combined With Chidamide in Treating Peripheral T Cell Lymphoma

Who this might be right for
Peripheral T-cell Lymphoma
Fudan University 51
Testing effectiveness (Phase 2)Study completedNCT01111526
What this trial is testing

Histone Deacetylase Inhibitor LBH589 in Addition to Corticosteroids in Patients With Acute Graft Versus Host Disease (GVHD)

Who this might be right for
Graft-Versus-Host Disease
H. Lee Moffitt Cancer Center and Research Institute 22
Early research (Phase 1)Study completedNCT02909452
What this trial is testing

Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors

Who this might be right for
NeoplasmsNeoplasms, Glandular and EpithelialNeoplasms by Histologic Type+11 more
Syndax Pharmaceuticals 30
Testing effectiveness (Phase 2)Study completedNCT00773838
What this trial is testing

Study of Vorinostat (MK0683), an Histone Deacetylase (HDAC) Inhibitor in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma (MK-0683-095)

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Merck Sharp & Dohme LLC 143
Testing effectiveness (Phase 2)Study completedNCT00792467
What this trial is testing

Trial of the Histone-Deacetylase Inhibitor ITF2357 Followed by Mechlorethamine in Relapsed/Refractory Hodgkin's Lymphoma

Who this might be right for
Hodgkin's Lymphoma
Italfarmaco 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT01305499
What this trial is testing

A Trial to Evaluate Two Schedules of MS275 in Combination With 5AC in Elderly Patients With Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Hetty Carraway 52
Testing effectiveness (Phase 2)Ended earlyNCT03002623
What this trial is testing

CUDC-907 Treatment in People With Metastatic and Locally Advanced Thyroid Cancer

Who this might be right for
Thyroid NeoplasmsPoorly Differentiated and Undifferentiated Thyroid CancerDifferentiated Thyroid Cancer
National Cancer Institute (NCI) 7
Testing effectiveness (Phase 2)Study completedNCT00621244
What this trial is testing

Oral LBH589 in Adult Patients With Advanced Hematological Malignancies

Who this might be right for
LymphomaLeukemiaMultiple Myeloma
Novartis Pharmaceuticals 175
Not applicableStudy completedNCT03460444
What this trial is testing

The Effect of Raising Ketones Directly With MCT Oil on Inflammation in Healthy Young Adults

Who this might be right for
MCT Oil Supplementation
University of British Columbia 15
Testing effectiveness (Phase 2)Ended earlyNCT01090830
What this trial is testing

Safety and Efficacy of Belinostat When Used With Standard of Care Chemotherapy for Untreated Non-small Cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Carcinoma
Holy Cross Hospital, Florida 7
Testing effectiveness (Phase 2)Study completedNCT00843167
What this trial is testing

Broccoli Sprout Extract in Treating Women Who Have Had a Mammogram and Breast Biopsy

Who this might be right for
Breast CancerPrecancerous Condition
OHSU Knight Cancer Institute 54
Testing effectiveness (Phase 2)UnknownNCT03373019
What this trial is testing

Chidamide Combined With R-GDP in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Who this might be right for
ChidamideLymphoma, B-CellLymphoma, Large B-Cell, Diffuse+13 more
Fudan University 63
Testing effectiveness (Phase 2)UnknownNCT02759601
What this trial is testing

Dose Escalation Trial of Tefinostat for Cancer Associated Inflamation in Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Queen Mary University of London 69
Testing effectiveness (Phase 2)Study completedNCT00589290
What this trial is testing

Belinostat (PXD101) to Treat Tumors of the Thymus at an Advanced Stage

Who this might be right for
ThymomaThymic Carcinoma
National Cancer Institute (NCI) 41
Load More Results